West China Hospital | China
Author Profile:
Scopus
Orcid
📘 EARLY ACADEMIC PURSUITS
Cheng Shen began his academic journey at Kunming Medical University, earning his Bachelor of Medicine in Clinical Medicine in 2011. His passion for clinical excellence and research led him to the West China School of Medicine, Sichuan University, where he pursued a Ph.D. in Thoracic Surgery while simultaneously working as a Resident Doctor and Research Assistant from 2011 to 2017. During this period, he honed his clinical and research acumen, laying a strong foundation for his future contributions to oncology and thoracic surgery.
🩺 PROFESSIONAL ENDEAVORS
Dr. Cheng Shen currently serves as an Attending Physician in the Department of Thoracic Surgery at West China Hospital, Sichuan University. His international academic exposure includes his time as a Visiting Scholar at Yale University (2015–2016) in the Department of Molecular Biophysics and Biochemistry, where he advanced his expertise in molecular mechanisms of DNA repair. This blend of clinical practice and laboratory precision has equipped him to lead cutting-edge investigations in thoracic oncology.
🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC SURGERY
Dr. Shen’s research spans several high-impact domains, including:
-
Targeted Gene Therapy and Immunotherapy
-
Molecular Mechanisms of Cancer Invasion and Metastasis
-
Cell and Tissue Engineering
-
Stem Cell Function and Differentiation
His research during his Yale tenure focused on the mechanism of homology-directed DNA repair, using yeast and human models. He also explored genomic instability in primary lung cancers and conducted studies on cancer-associated fibroblasts in lung adenocarcinoma.
🌐 IMPACT AND INFLUENCE
Cheng Shen has contributed significantly to the understanding of tumor biology, particularly in thoracic malignancies. His ability to translate complex molecular biology into practical clinical insights makes him a crucial figure in personalized cancer therapy. He has also designed and led several small clinical trials, emphasizing his commitment to bridging the bench-to-bedside gap.
🏅 ACADEMIC CITES AND COLLABORATIONS
While specific citation counts are not provided, his training at Yale University, multiple national-level scholarships, and leadership in clinical trials reflect a robust academic profile. His research work is likely referenced in the fields of genomic instability, lung cancer, and DNA repair mechanisms.
🚀 LEGACY AND FUTURE CONTRIBUTIONS
Dr. Cheng Shen’s future appears poised for further breakthroughs in thoracic cancer treatment and regenerative medicine. As a physician-scientist with deep laboratory roots and clinical experience, he is uniquely positioned to drive innovation in cancer therapy, particularly with emerging gene and cell-based interventions. His trajectory indicates continued leadership in integrative and translational medical research.
🏆 OTHER IMPORTANT AREAS OF EXCELLENCE
LANGUAGE PROFICIENCY:
-
Advanced in English, having cleared PETS-3, PETS-4, CET-4, and CET-6.
LAB PROFICIENCY:
-
Expertise in PCR, Western Blot, ELISA, Cell Culture, and Signaling Pathway Inhibition.
-
Strong in Animal Models and Transwell Cell Migration assays.
HONORS & SCHOLARSHIPS:
-
State Scholarship Fund (CSC) (2015–2017)
-
National Graduate Scholarships (2012–2014)
-
Full Scholarship from Sichuan University (2011–2016)
-
Multiple Merit Scholarships during undergraduate studies
NOTABLE PUBLICATIONS
"Accuracy of Large Language Models for Literature Screening in Thoracic Surgery: Diagnostic Study"
Authors: ZY Dai, FQ Wang, C Shen, YL Ji, ZY Li, Y Wang, Q Pu
Journal: Journal of Medical Internet Research
Year: 2025
"A combined subsegmentectomy of right S9 + 10b with single direction thoracoscopic surgery"
Authors: C Shen, C Liu
Journal: Journal of Cardiothoracic Surgery
Year: 2024
"Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta-analysis"
Authors: Shen C, Li J, Li J, Che G
Journal: Thoracic Cancer
Year: 2022